P110: Outcome of high-dose chemotherapy (HDCT) and autologous stem cell transplant (ASCT) as first salvage treatment for relapsed or refractory classical Hodgkin Lymphoma (cHL) in the era of PET-adapted strategy among Italian centers

Detalles Bibliográficos
Autores principales: Viviani, Simonetta, Vanazzi, Anna, Frassoni, Samuele, Rusconi, Chiara, Rossi, Andrea, Romano, Alessandra, Patti, Caterina, Schiavotto, Corrado, Sorasio, Roberto, Marasco, Vincenzo, Lissandrini, Laura, Rapezzi, Davide, Gottardi, Daniela, Cocito, Federica, Mulè, Antonino, Gini, Guido, Zanotti, Roberta, Rambaldi, Alessandro, Bagnardi, Vincenzo, Tarella, Corrado
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Relapsed/Refractory
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9621533/
http://dx.doi.org/10.1097/01.HS9.0000891008.01210.7b
Descripción
Sumario:

Ejemplares similares